CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Neurocrine Biosciences Inc Company Snapshot
Neurocrine Biosciences Inc operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Neurocrine Biosciences Inc with three other companies in this sector in the United States: Vical Incorporated (2015 sales of $20.95 million of which 100% was Biopharmaceutical), Acceleron Pharma Inc ($18.10 million ), and Enzon Pharmaceuticals, Inc. ($17.46 million ).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Neurocrine Biosciences Inc
  Stock Performance Chart for Neurocrine Biosciences Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 42.25
(Figures in U.S. Dollars)
1 Week -4.1%   13 Weeks -0.5%  
4 Weeks 0.0%   52 Weeks -11.2%  
 
Neurocrine Biosciences Inc Key Data:
  Ticker: NBIX Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2015 Sales 19,769,000
(Year Ending Jan 2016).
Employees: 120
  Currency: U.S. Dollars Market Cap: 3,670,312,974
  Fiscal Yr Ends: December Shares Outstanding: 86,871,313
  Share Type: Common Closely Held Shares: 1,028,119
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.